Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.

Also called NCT07571447

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Phase 4
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07571447
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07571447. Randomized; no masking; primary purpose health services research. Start 2026-09 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation
Acronym
CARDIOZOLAM-1
Condition
Atrial Fibrillation (AF)
Intervention (Other)
One-step cardiologist-only midazolam sedation
Intervention (Other)
Two-step anaesthesiologist-assisted propofol sedation
Lead sponsor
Gødstrup Hospital (class: other)
Collaborator
University of Aarhus (class: other)

Record details

Record id
cardio:ct-nct07571447
Content hash
8f9ba4e0eee88cf64ba90740902ce7952683aa9040f48941187ddb14b54d3c72